| Title |
Erythropoietin as candidate for supportive treatment of severe COVID-19
|
|---|---|
| Published in |
Molecular Medicine, June 2020
|
| DOI | 10.1186/s10020-020-00186-y |
| Pubmed ID | |
| Authors |
Hannelore Ehrenreich, Karin Weissenborn, Martin Begemann, Markus Busch, Eduard Vieta, Kamilla W. Miskowiak |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 14% |
| India | 1 | 7% |
| Bolivia, Plurinational State of | 1 | 7% |
| Germany | 1 | 7% |
| Spain | 1 | 7% |
| Unknown | 8 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 86% |
| Practitioners (doctors, other healthcare professionals) | 1 | 7% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 157 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 17 | 11% |
| Researcher | 14 | 9% |
| Student > Doctoral Student | 14 | 9% |
| Other | 13 | 8% |
| Student > Ph. D. Student | 9 | 6% |
| Other | 34 | 22% |
| Unknown | 56 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 24% |
| Biochemistry, Genetics and Molecular Biology | 14 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
| Nursing and Health Professions | 7 | 4% |
| Psychology | 6 | 4% |
| Other | 28 | 18% |
| Unknown | 56 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 115. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 December 2023.
All research outputs
#358,431
of 25,152,132 outputs
Outputs from Molecular Medicine
#13
of 1,259 outputs
Outputs of similar age
#10,213
of 377,973 outputs
Outputs of similar age from Molecular Medicine
#1
of 15 outputs
Altmetric has tracked 25,152,132 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,259 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 377,973 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.